Benefit of everolimus as a monotherapy for a refractory breast cancer patient bearing multiple genetic mutations in the PI3K/AKT/mTOR signaling pathway

A postmenopausal patient with a diagnosis of estrogen receptor (ER) (+), progesterone receptor (PR) (+), and human epidermal growth factor receptor-2 (HER2) (-) breast cancer was reported. The patient refused surgery and was resistant to conventional chemotherapy regimens. Computed tomography and th...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Yehui, Zhang, Wenwen, Ye, Yingnan, Cheng, Yanan, Han, Lei, Liu, Pengpeng, Zhao, Weipeng, Tong, Zhongsheng, Yu, Jinpu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chinese Anti-Cancer Association 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6121052/
https://www.ncbi.nlm.nih.gov/pubmed/30197799
http://dx.doi.org/10.20892/j.issn.2095-3941.2017.0188

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6121052/
https://www.ncbi.nlm.nih.gov/pubmed/30197799
http://dx.doi.org/10.20892/j.issn.2095-3941.2017.0188

Ejemplares similares